HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Michael Gibson Selected Research

cangrelor

3/2022Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION.
1/2022Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX.
3/2019Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial.
1/2019Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention.
1/2019Periprocedural Outcomes According to Timing of Clopidogrel Loading Dose in Patients Who Did Not Receive P2Y12 Inhibitor Pretreatment.
12/2018Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial.
3/2018Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience.
1/2018Cangrelor compared with clopidogrel in patients with prior myocardial infarction - Insights from the CHAMPION trials.
1/2018Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition).
10/2017Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Michael Gibson Research Topics

Disease

220Myocardial Infarction
11/2022 - 01/2002
139Hemorrhage
12/2022 - 02/2002
131ST Elevation Myocardial Infarction
06/2022 - 03/2002
100Thrombosis (Thrombus)
11/2022 - 07/2002
100Acute Coronary Syndrome
06/2022 - 04/2002
51Infarction (Infarctions)
01/2022 - 01/2002
45Ischemia
03/2022 - 02/2002
33Stroke (Strokes)
03/2022 - 09/2005
31Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 04/2002
27Heart Failure
01/2021 - 03/2002
24Atrial Fibrillation
01/2021 - 05/2005
23Unstable Angina
05/2017 - 02/2002
19Venous Thromboembolism
02/2020 - 03/2014
16Non-ST Elevated Myocardial Infarction
11/2020 - 11/2002
11Pathologic Constriction (Stenosis)
01/2016 - 02/2002
10Coronary Artery Disease (Coronary Atherosclerosis)
01/2021 - 11/2002
10Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2020 - 04/2003
9Inflammation (Inflammations)
06/2022 - 02/2003
9Death (Near-Death Experience)
11/2020 - 11/2013
8Pulmonary Embolism
11/2020 - 05/2005
8Diabetes Mellitus
01/2020 - 10/2002
8Venous Thrombosis (Deep-Vein Thrombosis)
12/2018 - 01/2015
7COVID-19
01/2022 - 01/2020
7Atherosclerosis
01/2022 - 02/2003
6Stable Angina
11/2018 - 08/2004
6Hypertension (High Blood Pressure)
01/2014 - 02/2003
5Necrosis
06/2022 - 05/2005
5Chest Pain (Chest Pains)
01/2020 - 05/2002
5Renal Insufficiency (Renal Failure)
01/2020 - 02/2003
4Rupture
01/2022 - 06/2003
4Infections
12/2021 - 10/2005
4Chronic Renal Insufficiency
12/2021 - 06/2014
4Shock
01/2021 - 06/2002
4Reperfusion Injury
12/2019 - 04/2013

Drug/Important Bio-Agent (IBA)

58Clopidogrel (Plavix)FDA Link
01/2022 - 08/2004
38Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2022 - 12/2002
35Glycoproteins (Glycoprotein)IBA
08/2021 - 11/2002
29cangrelorIBA
03/2022 - 12/2009
27Enoxaparin (Lovenox)FDA LinkGeneric
02/2020 - 04/2002
26Biomarkers (Surrogate Marker)IBA
06/2022 - 04/2002
252'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
12/2022 - 07/2013
25RivaroxabanIBA
11/2019 - 05/2011
23N(2)-(3-trifluoromethylphenyl)guanineIBA
06/2022 - 01/2002
21Abciximab (ReoPro)FDA Link
10/2016 - 07/2003
21Eptifibatide (Integrilin)FDA Link
04/2014 - 04/2003
19omega-Chloroacetophenone (Mace)IBA
11/2020 - 02/2009
19Heparin (Liquaemin)FDA LinkGeneric
07/2020 - 12/2002
19Tirofiban (Aggrastat)FDA Link
01/2012 - 07/2002
18AnticoagulantsIBA
01/2021 - 03/2005
17Fibrinolytic Agents (Antithrombotic Agents)IBA
07/2020 - 10/2002
17betrixabanIBA
02/2020 - 03/2014
16TicagrelorIBA
03/2022 - 07/2013
16Pharmaceutical PreparationsIBA
01/2022 - 03/2002
16bivalirudin (Angiomax)FDA Link
01/2017 - 05/2006
15Vitamin KFDA Link
01/2021 - 06/2012
13TenecteplaseFDA Link
01/2020 - 04/2003
11TroponinIBA
01/2020 - 07/2002
11AntithrombinsIBA
01/2020 - 04/2002
10C-Reactive ProteinIBA
06/2022 - 04/2002
10S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA
01/2020 - 04/2002
10fibrin fragment D (D-dimer)IBA
01/2020 - 01/2015
9Brain Natriuretic Peptide (Natrecor)FDA Link
06/2022 - 04/2002
9ThrombinFDA Link
01/2020 - 06/2006
9MB Form Creatine KinaseIBA
04/2016 - 01/2002
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 10/2005
8Factor Xa InhibitorsIBA
03/2019 - 05/2011
8Prasugrel HydrochlorideFDA Link
01/2019 - 10/2006
8GadoliniumIBA
08/2014 - 01/2006
7CreatinineIBA
01/2019 - 11/2003
7Tissue Plasminogen Activator (Alteplase)FDA Link
01/2018 - 05/2003
7Platelet Membrane Glycoprotein IIbIBA
02/2016 - 05/2007
6eicosapentaenoic acid ethyl esterIBA
01/2022 - 01/2020
6Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2022 - 12/2009
6CholesterolIBA
01/2022 - 04/2009
6Warfarin (Coumadin)FDA LinkGeneric
11/2019 - 06/2012
6Troponin IIBA
01/2016 - 04/2002
5CSL112IBA
01/2022 - 10/2016
5LipidsIBA
01/2022 - 04/2009
5Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2022 - 10/2016
5Purinergic P2Y Receptor AntagonistsIBA
08/2020 - 12/2009
5Platelet Membrane GlycoproteinsIBA
01/2020 - 06/2004
5Factor Xa (Coagulation Factor Xa)IBA
01/2019 - 01/2012
4Troponin T (Troponin T1)IBA
06/2022 - 07/2002
4LDL CholesterolIBA
03/2022 - 12/2018
4arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA
12/2019 - 04/2013
4StreptokinaseFDA Link
01/2018 - 12/2009
4thienopyridineIBA
05/2015 - 11/2007

Therapy/Procedure

152Percutaneous Coronary Intervention
06/2022 - 04/2002
145Therapeutics
11/2022 - 02/2002
72Stents
11/2022 - 01/2002
32Thrombolytic Therapy
11/2012 - 10/2002
24Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2020 - 07/2002
12Patient Readmission
11/2019 - 04/2004
10Drug-Eluting Stents
11/2022 - 06/2003
9Thrombectomy
10/2016 - 03/2011
6Blood Transfusion (Blood Transfusions)
01/2018 - 06/2007
5Drug Therapy (Chemotherapy)
01/2021 - 04/2007
4Secondary Prevention
03/2019 - 03/2007
4Catheters
11/2018 - 07/2002
4Length of Stay
01/2016 - 06/2002